Dynamic splinting for hallux valgus – a prospective randomized study

Dynamic splinting for hallux valgus – a prospective randomized study - Hallux Orthosis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

DRKS

Registry ID

DRKS00013920

Enrollment

Registered

2018-01-29

Start date

2011-05-12

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M20.1

Interventions

Group 1: Treatment with Hallux valgus splint (Halluxsan) Group 2: natural history of hallux valgus without treatment

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: symptomatic hallux valgus wear time of the splint for at least 3 months

Exclusion criteria

Exclusion criteria: hindfoot deformities, degenerative changes of the MTP 1, preoperated hallux valgus, hereditary soft-tissue disease, inflammatoric skin disease, circulatory disorder, polyneuropathy and BMI > 40

Design outcomes

Primary

Measure	Time frame
After a treatment of at least 3 months with the halluxsan Hallux valgus splint the on a a.p. foot x-ray measured Hallux valgus angle shows a reduction.	—

Secondary

Measure	Time frame
After a treatment period of at least 3 months there is a pain reduction, measured on a NRS (Numeric Rating Scale), compared to the preintervention state.	—

Countries

Germany

Contacts

Public ContactChristian Plaass

Orthopädische Klinik der MHH am DIAKOVERE Annastift

christian.plaass@diakovere.de+495115354528

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026